Keyphrases
Ewing Sarcoma
90%
Ewing Sarcoma Family of Tumors
51%
T Cells
50%
Granulocyte Colony-stimulating Factor (G-CSF)
35%
Interleukin-2
34%
Bone Marrow Transplantation
32%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
30%
Tumor
29%
Bone Marrow
20%
Interleukin-10
18%
Transgenic
18%
Graft-versus-host Disease (GvHD)
18%
Allogeneic Bone Marrow Transplantation
16%
Malignancy
16%
Event-free Survival
15%
EWS-FLI1
15%
T Cell Receptor
13%
Tumor Cells
12%
Pulmonary Alveolar Proteinosis
12%
Osteosarcoma
12%
Interleukin-6
12%
Solid Tumors
11%
Tumor Patients
11%
High-dose Chemotherapy
10%
Melphalan
10%
Pediatric Oncology
10%
Primitive Neuroectodermal Tumor
10%
High Risk
10%
B Cells
9%
Overall Survival
9%
Childhood Cancer
9%
Aplastic Anemia
9%
High Dose
9%
Clinical Course
9%
Natural Killer Cells
9%
Risk Factors
9%
Capillary Leak Syndrome
9%
Metastasis
9%
Cyclosporine
9%
Neuroblastoma
9%
Poor Prognosis
9%
Etoposide
9%
Chondromodulin-1
8%
CD8+ T Cells
8%
Interleukin-3
8%
HLA-A*02
8%
Soluble interleukin-2 Receptor (sIL-2R)
8%
HLA Matching
8%
Interferon-α (IFN-α)
8%
Acute Myeloid Leukemia
8%
Medicine and Dentistry
Ewing Sarcoma
100%
Neoplasm
39%
T Cell
37%
Disease
31%
Bone Marrow Transplantation
28%
Granulocyte Macrophage Colony Stimulating Factor
18%
Pediatrics
17%
Event Free Survival
15%
Receptor
15%
Childhood Cancer
15%
Adolescent
15%
Stem Cell
14%
Metastatic Carcinoma
14%
Drug Megadose
12%
Allogeneic Stem Cell Transplantation
12%
Solid Malignant Neoplasm
12%
Emergency Medical Technician
11%
In Vitro
11%
Transplantation
11%
Overall Survival
11%
Lung Alveolus Proteinosis
10%
High Dose Chemotherapy
10%
Interleukin 2
10%
Melphalan
10%
Cancer
10%
Ganglioneuroblastoma
10%
Infection
10%
Cytokine
10%
B Cell
10%
Diagnosis
9%
Aplastic Anemia
9%
T Lymphocyte Receptor
9%
Immunotherapy
8%
Disease Course
8%
Etoposide
8%
Cell Line
8%
Personalized Medicine
8%
Radiation Therapy
8%
Cytotoxic T-Cell
7%
Tumor Cell
7%
Targeted Therapy
7%
DNA Microarray
7%
Sarcoma
7%
Rhabdomyosarcoma
7%
Symptom
7%
Gene Expression
7%
Malignant Neoplasm
6%
Stem Cell Therapy
6%
Pediatrics Patient
6%
HLA-A
6%
Immunology and Microbiology
T Cell
67%
Bone Marrow Transplantation
27%
Cytokine
25%
Transgenics
24%
Interleukin 2
23%
Immunotherapy
21%
Granulocyte Macrophage Colony-Stimulating Factor
16%
B Cell
16%
T Cell Receptor
16%
Transplant Procedure
15%
Mouse
15%
Cell Line
13%
Myeloid
12%
Tumor Cell
12%
Stem Cell
12%
Allogeneic Stem Cell Transplantation
12%
Interleukin 10
11%
Drug Megadose
10%
Cytotoxic T-Cell
10%
Allogeneic Bone Marrow Transplantation
10%
Capillary
9%
Tumor Necrosis Factor
9%
Aplastic Anemia
9%
Graft-Versus-Host Disease
9%
CD3 Antigen
8%
Monocyte
8%
Dendritic Cell
8%
Interleukin 7
7%
Interleukin 2 Receptor
7%
Engraftment
7%
Gene Expression
6%
Tumor Cell Line
6%
Natural Killer Cell
6%
Interleukin 6
6%
Tumor Antigen
6%
Event Free Survival
6%
T Cell Activation
6%
Cytotoxic T Cell
6%
Interleukin 3
6%
T-Helper Cell
6%
Granulocyte Colony-Stimulating Factor
5%
Autologous Stem Cell Transplantation
5%
Interferon Type I
5%
Genetic Transfection
5%
Fibroblast
5%
Upregulation
5%
Cell Function
5%
Epigenetics
5%
Cyclophosphamide
5%
Epithelial Membrane Antigen
5%
